Journal of Neuroinfectious Diseases
Open Access

Infectious diseases have historically been among the leading causes of death worldwide, particularly in children. The development and use of vaccines have transformed the landscape of global health, drastically reducing mortality and morbidity from illnesses once considered inevitable. Vaccine-preventable infections (VPIs) are those that can be effectively avoided through immunization. These include measles, diphtheria, tetanus, pertussis, polio, hepatitis B, influenza, and more recently, human papillomavirus (HPV). Despite major progress, VPIs continue to pose a threat due to gaps in vaccination coverage, inequities in access, and rising vaccine hesitancy [1,2].

Discussion

Vaccination programs have led to some of the most remarkable successes in modern medicine. Smallpox, once responsible for millions of deaths annually, has been eradicated through global immunization efforts. Polio, another devastating disease, has been nearly eliminated, with only a few countries still reporting cases. Similarly, measles and rubella have been drastically reduced in regions with robust immunization programs. These achievements highlight the power of vaccines not only to control but, in some cases, completely eliminate diseases [3-6].

Despite these successes, VPIs remain a persistent challenge. Measles, for example, continues to cause outbreaks in areas with declining vaccination rates, often fueled by misinformation and vaccine refusal. Pertussis, or whooping cough, remains endemic despite widespread vaccine use, with infants being the most vulnerable to severe complications. Influenza, though less feared than other infections, causes significant seasonal illness and death, particularly in older adults and individuals with chronic conditions. Hepatitis B and HPV represent another dimension of VPIs, as both viruses are linked to long-term complications like liver cancer and cervical cancer, respectively. Their vaccines not only prevent infections but also reduce cancer risks, underlining the broader health benefits of immunization [7,8].

The economic and societal impact of vaccines is equally important. By preventing illness, vaccination programs reduce hospitalizations, healthcare costs, and productivity losses. Furthermore, herd immunity plays a critical role in protecting vulnerable individuals who cannot be vaccinated due to age or medical conditions. When vaccination coverage drops, these protections weaken, leading to preventable outbreaks and unnecessary loss of life [9,10].

Global challenges continue to hinder progress. Vaccine hesitancy, often driven by misinformation on social media, threatens decades of public health gains. Additionally, low-resource regions face barriers such as limited healthcare infrastructure, supply shortages, and conflict, all of which restrict access to vaccines.

Conclusion

Vaccine-preventable infections remain a critical concern despite the remarkable success of immunization in reducing disease burden. Vaccines have saved countless lives, prevented disabilities, and offered long-term economic benefits. However, the persistence of VPIs due to gaps in coverage, misinformation, and inequities underscores the need for renewed global commitment. Strengthening vaccination programs, ensuring equitable access, and addressing hesitancy through education are essential steps toward safeguarding future generations. Ultimately, preventing vaccine-preventable infections is not only a matter of protecting individual health but also of securing the well-being and resilience of societies worldwide.

References

1. Amudhan S, Gururaj G, Satishchandra P (2015) Epilepsy in India I: Epidemiology and public health. Ann Indian Acad Neurol 18: 263-277.

   Indexed at, Google Scholar, Cross Ref

2. Nash TE, Garcia HH (2011) Diagnosis and Treatment of Neurocysticercosis. Nature reviews Neurology 7: 584-594.

   Indexed at, Google Scholar, Cross Ref

3. Garcia HH, Nash TE, Del Brutto OH (2014) Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurol 13: 1202-1215.

   Indexed at, Google Scholar, Cross Ref

4. Kimura-Hayama E T, Higuera J A, Corona-Cedillo R, Chávez-Macías L, Perochena A, et al. (2010) Neurocysticercosis: radiologic-pathologic correlation. Radiographics 30: 1705-1719.

   Indexed at, Cross Ref

5. Lerner A, Shiroishi MS, Zee CS (2012) Imaging of neurocysticercosis. Neuroimaging Clin N Am 22: 659.

   Indexed at, Google Scholar, Cross Ref

6. Castillo M (2004) Imaging of neurocysticercosis. Semin Roentgenol 39: 465-473.

   Indexed at, Google Scholar, Cross Ref

7. Hingwala, Divyata (2011) Applications of 3D CISS Sequence for Problem Solving in Neuroimaging. The Indian Journal of Radiology Imaging 21: 90-97.

   Indexed at, Google Scholar, Cross Ref

8. Govindappa SS, Narayanan JP, Krishnamurthy VM (2000) Improved detection of intraventricular cysticercal cysts with the use of three-dimensional constructive interference in steady state MR sequence. AJNR Am J Neuroradiol 21: 679-684.

   Indexed at, Google Scholar

9. Zhao J L, Lerner A, Sh Z, Gao X J, Zee C S (2015) Imaging spectrum of neurocysticercosis. Radiology of Infectious Diseases, 1: 94-102.

   Indexed at, Google Scholar, Cross Ref

10. Braga F, Rocha A J, Gomes H R, Hernandez Filho G, Fonseca RB (2004) Noninvasive MR cisternography with fluid-attenuated inversion recovery and 100% supplemental O2 in the evaluation of neurocysticercosis. AJNR Am J Neuroradiol 25: 295-297.

    Indexed at, Google Scholar